OTCMKTS:DCHPF Dechra Pharmaceuticals (DCHPF) Stock Price, News & Analysis $46.90 0.00 (0.00%) As of 01/18/2024 Add Compare Share Share Stock Analysis Stock Analysis About Dechra Pharmaceuticals Stock (OTCMKTS:DCHPF) Get Dechra Pharmaceuticals alerts:Sign Up Key Stats Today's Range$46.90▼$46.9050-Day Range$46.90▼$46.9052-Week Range$30.00▼$47.40VolumeN/AAverage Volume1,687 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Dechra Pharmaceuticals is a United Kingdom-based international veterinary pharmaceutical company that develops, manufactures and markets prescription medicines and related products for companion animals, horses and livestock. Its portfolio includes treatments for dermatology, endocrinology, anesthesia, pain management, ophthalmology, cardiology and critical care, as well as veterinary nutritional products. The company operates through veterinary-focused commercial and manufacturing businesses, supplying products primarily through veterinary practices, animal health distributors and other professional channels. Dechra serves markets across Europe, North America, Australia and New Zealand, Brazil and other international regions. Founded in 1997, Dechra expanded through internal product development, acquisitions and partnerships with other animal-health companies. In 2023, the company was acquired by EQT through a recommended cash offer, and its shares were subsequently delisted from the London Stock Exchange. Dechra is headquartered in Northwich, England.AI Generated. May Contain Errors. Read More Receive DCHPF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Dechra Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. DCHPF Stock News HeadlinesDechra Pharmaceuticals PLC (LON:DPH) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future?May 13, 2022 | finance.yahoo.comFTSE 100 firms hit boardroom diversity targets but fail at executive levelMarch 16, 2022 | uk.finance.yahoo.comTrump’s issues shocking Executive Order on U.S. DollarThree days into his second term, President Trump signed Executive Order 14178 a move the press barely covered. Buried inside is what some call the legal groundwork for the biggest change to American money in over a century, with a key Treasury vote potentially as soon as January 18. Ian King, Chief Strategist at Strategic Fortunes, breaks down what the order could mean for the dollar and the financial system.October 26 at 1:00 AM | Banyan Hill Publishing (Ad)Anivive Licenses Novel Canine Cancer Therapeutic to Expand Sales and Accelerate PipelineJanuary 12, 2022 | prnewswire.comDechra Pharmaceuticals (LON:DPH) Will Pay A Larger Dividend Than Last Year At UK£0.29September 14, 2021 | finance.yahoo.comGoldman Sachs picks London for private-equity IPO as FTSE climbs after U.S. jobs dataSeptember 6, 2021 | finance.yahoo.comCalculating The Fair Value Of Dechra Pharmaceuticals PLC (LON:DPH)August 7, 2021 | finance.yahoo.comSee More Headlines DCHPF Stock Analysis - Frequently Asked Questions How have DCHPF shares performed this year? Dechra Pharmaceuticals' stock was trading at $46.90 at the beginning of 2026. Since then, DCHPF stock has increased by 0.0% and is now trading at $46.90. Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorHealthcare Industry Pharmaceuticals Sub-IndustryPharmaceuticals Current SymbolOTCMKTS:DCHPF CIKN/A Webdechra.com Phone441606814730FaxN/AEmployees2,457Year FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 10 Best Stocks to Own in Fall 2026AI spending is reshaping the market, and the opportunity extends far beyond the biggest chipmakers. Discover 10 stocks set to benefit from powerful trends in AI infrastructure, cloud computing, energy, capital returns, and consumer growth this fall.Get This Free Report This page (OTCMKTS:DCHPF) was last updated on 1/18/2024 by MarketBeat.com Staff. From Our PartnersYour Social Security check is scheduled for a 22% cutThe U.S. now borrows money just to pay interest on money it already borrowed, a pattern economists call a debt...American Alternative | SponsoredTrump’s Plan To Cheat HistoryChina has slashed its U.S. Treasury holdings by more than 45% from their peak, while building gold vaults and ...Porter & Company | SponsoredFinancial legend: “This is bad, really bad...”Dr. Martin D. Weiss has publicly predicted six major American financial crashes over his 55-year career leadin...Weiss Ratings | SponsoredYour book is insideBlane Markham and the Markham Trading Team are giving readers a limited window to download their options strat...TradeWins | SponsoredTrump’s issues shocking Executive Order on U.S. DollarThree days into his second term, President Trump signed Executive Order 14178 a move the press barely covered....Banyan Hill Publishing | SponsoredBeginner’s Guide to GoldInflation, trade wars, and market volatility have many savers rethinking how they protect retirement funds. A ...Goldco Direct, LLC | SponsoredLast call for your free 0DTE reportThe 0DTE Game Plan lays out a simple 3-step framework for trading same-day options: Plan it, profit from it, p...Profits Run | SponsoredAnd they say the headline number understates what’s really happening.Goldman Sachs just admitted it underestimated central bank gold purchases by more than 500 percent, with buyin...Cedar Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Dechra Pharmaceuticals PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share Dechra Pharmaceuticals With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
